A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2015; you can also visit the original URL.
The file type is
The objective of this research program is to optimize drug dose regimen for an individual, using minimally invasive clinical testing, in order to reduce both the total cost of treatment and the risk for over or under-medication using a Bayesian modeling approach. The challenge is to extract the PharmacoKinetic/PharmacoDynamic(PK/PD) parameters for an individual from population level plasma concentration information gathered in clinical trials along with one or two plasma samples from andoi:10.1109/wsc.2009.5429214 dblp:conf/wsc/BlauO09 fatcat:2vlupyge4vgwpgaot3sv4jbzay